Found 7 results
Name | Type of Offering | Accepted Date |
---|---|---|
Urigen Pharmaceuticals, Inc.
|
D | 2017-04-13 12:28:55 |
Amount To Be Raised
$15,000,000
Associated Brokers / Dealers
N/A
CIK Number
0000932352
Filed Document
0000932352-17-000002
Exclusions or Exemptions
506b
Accepted Date
2017-04-13 12:28:55
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
NEW JERSEY
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|
||
Urigen Pharmaceuticals, Inc.
|
D | 2013-07-19 |
Amount To Be Raised
$1,000,000
Associated Brokers / Dealers
N/A
CIK Number
0000932352
Filed Document
0000932352-13-000002
Exclusions or Exemptions
N/A
Accepted Date
2013-07-19
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
DELAWARE
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|
||
Urigen Pharmaceuticals, Inc.
|
D | 2018-02-07 10:31:02 |
Amount To Be Raised
$1,377,000
Associated Brokers / Dealers
N/A
CIK Number
0000932352
Filed Document
0000932352-18-000001
Exclusions or Exemptions
506b
Accepted Date
2018-02-07 10:31:02
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
NEW JERSEY
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Urigen Pharmaceuticals, Inc.
|
D/A | 2013-10-04 |
Amount To Be Raised
$856,000
Associated Brokers / Dealers
N/A
CIK Number
0000932352
Filed Document
0000932352-13-000003
Exclusions or Exemptions
506b
Accepted Date
2013-10-04
Type of Offering
D/A
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
DELAWARE
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|
||
Vaneltix Pharma, Inc.
|
D | 2024-01-24 11:13:11 |
Amount To Be Raised
$5,000,000
Associated Brokers / Dealers
N/A
CIK Number
0000932352
Filed Document
0000932352-24-000002
Exclusions or Exemptions
506b
Accepted Date
2024-01-24 11:13:11
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
NEW JERSEY
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Urigen Pharmaceuticals, Inc.
|
D | 2015-07-14 |
Amount To Be Raised
$12,365,759
Associated Brokers / Dealers
N/A
CIK Number
0000932352
Filed Document
0001144204-15-042368
Exclusions or Exemptions
506b
Accepted Date
2015-07-14
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
NEW JERSEY
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Urigen Pharmaceuticals, Inc.
|
D | 2020-11-20 13:08:03 |
Amount To Be Raised
$3,021,843
Associated Brokers / Dealers
N/A
CIK Number
0000932352
Filed Document
0000932352-20-000002
Exclusions or Exemptions
506b
Accepted Date
2020-11-20 13:08:03
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
NEW JERSEY
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|